Search

everythinglearnresearchcommunity

for

Search:↓

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Diagnosing new systemic lupus during pregnancy is hard but important for the health of the mother and baby.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Tjalma Syndrome is a rare condition in people with lupus, causing fluid buildup and high CA-125 levels, but not due to tumors.

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Lupus is a complex disease that requires personalized treatment because it varies greatly between individuals.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

Pregnant women with Systemic Lupus Erythematosus have a higher risk of blood clotting problems.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

The document concludes that treating tough skin disease in lupus involves sun protection, steroids, antimalarials, and various other therapies chosen based on individual risks and benefits.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The CLASI is a reliable tool for measuring the severity of cutaneous lupus erythematosus.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Anti-CD19 therapy may help treat SLE and NMOSD.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

SLE is rare in Uganda but often has complications and overlaps with rheumatoid arthritis.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.